What startups are building personalized mental health or psychiatry copilots for care teams?

Yes. As of September 2026, there’s a meaningful cluster of startups building AI around the clinician/care-team side of mental healthcare, rather than purely consumer-facing therapy bots.

I’d break the landscape into four buckets:

The most interesting direct matches

1. Callyope — probably the closest to a psychiatric intelligence layer. Its Copilot combines speech, sleep/activity signals and clinical information to produce patient-specific psychiatric insights; Google describes it as an AI copilot specifically for mental-health practitioners.Google for Startup+1

2. Blossom Health — probably the clearest AI psychiatrist + human psychiatrist model. The company raised $20M in 2026 and describes its product as an AI copilot for psychiatry; its platform is already being used by hundreds of clinicians treating 10,000+ patients.Fortune+1

3. Wysa Copilot — particularly interesting if you're thinking about extending the care team's reach between appointments. Clinicians can assign personalized interventions, monitor assessments/risk, communicate with patients and adapt care pathways based on progress.Wysa - Everyday Mental Health+1

4. Eleos — more mature on the care-team intelligence/workflow side. Its platform analyzes behavioral-health sessions, generates documentation and clinical insights, and in 2026 added AI agents spanning clinical insights, compliance and revenue-cycle workflows. It has also been selected as the statewide AI partner for California's county behavioral-health system.Eleos Health+2

5. Flourish Health — interesting because the care team itself is the product. Its psychiatrist-led Care Pods combine a child/adolescent psychiatrist, therapist, patient guide and family guide, with proprietary AI acting as the team's workflow layer. It raised $46M in total funding in July 2026.GlobeNewswire

6. Allia Health — one of the newer, more ambitious "mental-health OS" approaches. Rather than selling a standalone copilot, Allia is building an AI-native clinical group and shared system of record, coordinating therapy, psychiatry, primary care, referrals and outcomes. Its YC profile says 8,000+ clinicians are using its practice software, with 600+ activated into its clinical group.Y Combinator

A useful way to visualize the market

There are actually three different "copilot" architectures emerging:

A. Clinician intelligence

Patient data → AI synthesis → clinician decision Examples: Callyope, Eleos, CogniCare, Wellsheet

Callyope is the most psychiatry-specific example; Eleos is further along in behavioral-health organizational deployment.Callyope+1

B. Care-team augmentation

Clinician + AI → continuous patient engagement between visits Examples: Wysa, April Health, Lyra

This is arguably the most interesting category if by "personalized copilot" you mean an AI that knows the patient's care plan, history and goals, handles check-ins/interventions between encounters, and feeds information back to the human team. Wysa explicitly supports this model.Wysa - Everyday Mental Health+2

C. AI-native clinical delivery

AI performs portions of the clinical workflow → human supervises/escalates Examples: Legion Health, Blossom, Allia, Flourish

Legion is pushing furthest toward autonomous execution: its 2026 YC description says it has regulatory authorization for AI-powered psychiatric maintenance-medication renewals, while emphasizing escalation to clinicians.Y Combinator

If you're specifically looking for the startup opportunity

The interesting whitespace isn't really "AI therapist." That's crowded.

The more differentiated thesis is:

A longitudinal patient-specific intelligence layer for the entire mental-health care team. That means ingesting EHR + prior notes + assessments + medication history + patient-reported outcomes + messages + passive/behavioral signals, then maintaining a continuously updated patient state that different members of the team can query and act on.

The system could give a psychiatrist a different view than a therapist, care manager or PCP, while maintaining one underlying model of the patient.

That sits somewhere between Callyope's clinical intelligence, Wysa's between-session layer, Eleos's workflow intelligence, and Allia/Flourish's coordinated-care architecture.Callyope+3

One important caveat: the term "copilot" is being used very broadly. Some companies primarily automate documentation, some personalize digital interventions, and others are actually attempting clinical decision support or autonomous care. Those are substantially different businesses and risk profiles. The emerging literature also distinguishes assistive, collaborative and semi-autonomous psychiatric AI rather than treating all of these as the same thing.Nature

If you're doing competitive landscaping/investment research, I can also turn this into a 20–30 company map with founding year, funding, investors, customer type, clinical workflow, AI capabilities, traction, and a "how close is this to a true personalized psychiatry copilot?" column.

If by “personalized mental-health/psychiatry copilot” you mean software that sits alongside a clinician or care team, uses the patient’s longitudinal data/context, and helps with assessment, treatment planning, monitoring, documentation, or between-visit engagement, there’s a meaningful startup cluster here.

The most directly relevant companies

A few details distinguish the category:

• Blossom Health is probably the clearest example if you're specifically looking for an AI psychiatry copilot rather than a general behavioral-health EHR. It raised $20M in seed/Series A funding in March 2026 and says its platform pairs psychiatrists with clinical copilots and automated administrative support.Fortune+1
• Wysa Copilot is more explicitly a care-team/patient hybrid: clinicians can assign personalized interventions, monitor assessments, see risk events, communicate with patients and adapt care pathways between visits.Wysa - Everyday Mental Health+1
• CogniCare is unusually close to the “AI clinical team” concept: its agents handle assessment, diagnostic reasoning, treatment planning and progress tracking, while its LIAM copilot is grounded in the individual client's record.CogniCare
• is broader infrastructure. Its “Emma” clinical assistant handles documentation while other AI workers handle admissions and billing, all inside an AI-native behavioral-health EHR.

How I'd segment the market

There are really four overlapping wedges rather than one category:

1. Clinician copilot: Blossom, CogniCare, mdhub → “Make the psychiatrist/therapist substantially more productive.”
2. Patient copilot + clinician oversight: Wysa, Jimini → “Give patients continuous AI support while keeping the care team in the loop.”
3. Care-team operating system: Allia, mdhub, Levio → “Coordinate the entire behavioral-health workflow around a longitudinal patient record.”
4. AI-native/autonomous psychiatry: Legion, and to some extent Blossom → “Move portions of psychiatric care from clinician-led to AI-led, with escalation/supervision.”

There is also a large incumbent-adjacent group—Spring Health and Talkspace, for example—that is incorporating AI personalization and provider-facing AI into existing mental-health delivery rather than being pure-play “copilot startups.” Spring Health describes its model as AI-native precision mental healthcare, while Talkspace uses AI for provider notes/summaries, risk alerts and personalized between-session support.Spring Health+1

If you're doing competitive landscape / startup scouting, the especially interesting comparison is Blossom vs. Wysa vs. CogniCare vs. Jimini vs. mdhub vs. Allia: they represent quite different answers to where the AI should sit in the care loop.

Yes. If by “personalized mental health/psychiatry copilot for care teams” you mean software that sits alongside clinicians, maintains a longitudinal patient context, supports between-visit care, and helps a human team make/execute clinical decisions, there’s a fairly interesting emerging cohort.

Closest matches

• jiminihealth.com — Probably the closest conceptual match. Its Sage product is positioned as a behavioral-health AI care-team member working with both patients and clinicians. Jimini raised a $17M seed in March 2026 and describes Sage as enabling more continuous, personalized care while keeping clinicians in the loop.M13
• wysa.com — Wysa Copilot is explicitly built for care teams: clinicians can personalize/assign interventions, monitor patients between sessions, receive automated assessments and crisis signals, and use summaries to maintain continuity. It also has specific workflows for psychiatrists and primary-care behavioral-health teams.Wysa - Everyday Mental Health+1
• blossomhealth.com — An AI-native psychiatry platform whose stated goal is an AI “copilot” for psychiatry. As of March 2026, Fortune reported that Blossom was already being used by hundreds of clinicians treating 10,000+ patients and had raised $20M.Fortune
• flourish.health — Particularly interesting if you mean team-based/high-acuity psychiatry, rather than an individual psychiatrist's assistant. Flourish has psychiatrist-led “Care Pods” consisting of a psychiatrist, therapist, patient guide and family guide, with an AI platform coordinating workflow, patient touchpoints, EMR/prescribing and collaboration. It raised $46M total by July 2026.GlobeNewswire
• allia.health — A newer, more ambitious “AI-native clinical group” rather than just a copilot product. Allia says its intelligent system of record connects therapy, psychiatry, primary care and higher levels of care, with agentic technology monitoring longitudinal outcomes and identifying patients who may need treatment changes. YC lists it as a Summer 2026 company.Y Combinator+1
• cognicarehq.com — More clinician-workflow oriented. It describes an AI “clinical team” of specialized agents for assessment, diagnosis, treatment planning, progress tracking and documentation, plus LIAM, an in-session copilot grounded in the individual client's record.CogniCare
• levio-health.com — An emerging European mental-health clinical copilot. It combines intake/phone handling, consultations and follow-up on a connected patient record and says it has been validated with clinicians across several European countries.Levio Health

Adjacent companies worth watching

• Spring Health — Much larger/incumbent rather than an early startup now, but its platform is explicitly built around personalized/“precision” mental healthcare, and in 2026 it launched Guide, an AI-led experience designed around continuity of care.Spring Health+1
• April Health — A collaborative-care model combining behavioral-health care managers, consulting psychiatrists, Wysa's therapeutic coach and a clinician copilot. This is especially relevant to psychiatry-as-a-consulting-layer for primary care.April Health
• Attunio Health — Taking a more “precision psychiatry” approach, combining AI, biomarkers, wearables and clinician-guided treatment personalization; launched its platform in June 2026.PR Newswire

The market seems to be splitting into a few architectures

The particularly interesting gap, in my view, is between Wysa/Jimini-style patient-facing copilots and Flourish/Allia-style care-team infrastructure: a genuinely longitudinal psychiatric “case manager” that builds a patient model, monitors signals between visits, proposes interventions, coordinates therapist/psychiatrist/PCP tasks, and learns from treatment response—while leaving clinical decisions with humans. That's a somewhat different product category from ambient scribing or generic clinical documentation AI.

Yes. If by “personalized mental-health/psychiatry copilot” you mean AI that sits inside a clinician-led care model—using the patient’s longitudinal context, extending care between visits, surfacing risk/insights, or helping clinicians choose/execute treatment—the market is getting interesting in 2026.

The startups I’d put on the shortlist

1. Jimini Health — probably the closest fit

Jimini Health is unusually close to the “AI member of the care team” concept.

Its Sage product is explicitly described as an AI behavioral-health care-team member. The clinician establishes the patient's clinical priorities; Sage then interacts with the patient continuously between sessions, supports skills and adherence, detects situations requiring escalation, and shares progress with the clinician.Jimini Health+1

This isn't merely an AI scribe. Jimini raised $17M in March 2026 specifically to expand its clinician-supervised AI infrastructure with behavioral-health organizations.Jimini Health+1

Thesis: “Give every therapist an always-on AI teammate that knows the treatment plan and patient context.”

2. Blossom Health — AI-native psychiatry

Blossom Health is probably the company I'd watch most closely if your emphasis is specifically psychiatry rather than therapy.

Blossom raised $20M in seed + Series A funding in March 2026 and describes itself as an AI-native psychiatry platform. It was already being used by hundreds of clinicians treating more than 10,000 patients.Fortune

Its strategy is somewhat different from Jimini's: rather than primarily adding an AI companion to an existing therapy relationship, Blossom is rebuilding the psychiatric care-delivery stack around AI, with psychiatrists remaining central.

3. Wysa — the more established care-team copilot

Wysa has perhaps the clearest product-market definition around this concept.

Its Wysa Copilot lets care teams assign personalized interventions, monitor mood and screening results, communicate with patients, receive crisis/risk signals, and adapt care pathways. Wysa explicitly positions it for psychiatrists, primary care and integrated behavioral-health teams.Wysa - Everyday Mental Health+1

The interesting distinction is that Wysa is essentially “AI patient engagement + clinical monitoring + care-team workflow”, rather than an autonomous psychiatrist.

4. Limbic — AI embedded in the behavioral-health pathway

Limbic is another particularly strong contender.

Its platform has separate intake, triage and therapy agents. The triage system assesses needs and predicts diagnoses; Limbic Care then provides personalized conversational support between sessions while keeping escalation pathways connected to clinical staff.Limbic+1

It has also moved toward the clinician side: Limbic Care is positioned as an AI extension of the treatment plan, with caseload-management capabilities and a clinical AI assistant for providers.Limbic

Thesis: AI layer across the entire behavioral-health pathway, rather than one chatbot.

5. Eleos Health — the clinician-side version

Eleos Health is worth including even though it isn't primarily a patient-facing companion.

Its current platform has a Clinical Insights Agent that acts as an in-workflow clinical copilot, synthesizing client information and evidence-based guidelines to help providers with decisions around risk, evidence-based practices, substance-use disorder and CCBHC care. It also automates documentation, compliance and revenue-cycle workflows.Eleos Health+1

So I'd categorize Eleos as:

“AI copilot for the behavioral-health professional”

rather than:

“AI teammate that interacts directly with the patient.”

6. Aifred Health — personalized psychiatric treatment selection

Aifred Health is particularly interesting if personalization = choosing the right psychiatric treatment for this particular patient.

Its system predicts remission probabilities across available depression treatments using individual patient characteristics and provides physicians with decision support around medication and psychotherapy choices. Aifred says its model covers 10 first-line treatments/combinations and has been trained using data from more than 9,000 clinical-trial participants.Aifred Health

This is a much more focused thesis than the conversational copilots:

patient data → predicted treatment response → clinician decision

7. Flourish Health — AI-powered psychiatric Care Pods

Flourish Health is an interesting adjacent model.

It uses psychiatrist-led Care Pods consisting of a child/adolescent psychiatrist, therapist, patient guide and family guide. Its proprietary AI platform coordinates patient touchpoints, EMR/prescribing, workflow and team collaboration. Flourish raised $26M Series A in July 2026, bringing total funding to $46M.GlobeNewswire

The distinction is important: the AI isn't the care provider; it is the operating layer that makes a multidisciplinary psychiatric team economically scalable.

8. Allia Health — potentially the most ambitious system-level play

Allia Health is newer and takes the thesis further.

Rather than selling a copilot to individual therapists, Allia is building an AI-native mental-health medical group. Its system of record is intended to identify who is improving, disengaging or needing treatment changes across therapy, psychiatry, primary care and higher-acuity services. YC says the company had 600+ activated clinicians across 70 sites and 32 states as of its 2026 launch.Y Combinator

That's essentially:

AI + longitudinal patient record + coordinated provider network + payer contracts.

How I'd map the competitive landscape

There are really four different startups hiding under “mental-health copilot”:

• Patient-facing care-team member: Jimini, Wysa, Limbic
• Psychiatrist decision support: Blossom, Aifred
• Clinician workflow/clinical copilot: Eleos
• AI-native care delivery infrastructure: Allia, Flourish

And that's an important distinction. The most compelling emerging architecture, in my view, is not “AI therapist.” It's:

Patient ↔ personalized AI layer ↔ human care team ↔ longitudinal clinical record Jimini is probably the purest example of that architecture today: the AI knows the clinician's goals, works with the patient continuously, and feeds information back to the human team rather than trying to replace it.Jimini Health+1

If you're doing competitive/market mapping, I would put Jimini, Blossom, Wysa, Limbic, Eleos, Aifred, Allia, and Flourish in the core set, and then map them by patient-facing ↔ clinician-facing and workflow automation ↔ clinical intelligence. That produces a much more informative landscape than a generic list of “AI mental health startups.”

Yes. If by “personalized mental-health/psychiatry copilot” you mean AI that sits alongside a clinician/care team, maintains longitudinal patient context, and helps with assessment, treatment, engagement, monitoring, or care coordination—not just an ambient scribe—the market is getting interesting.

The startups I’d watch

The most interesting distinction

I'd divide these into three different bets:

1. “AI becomes a member of the care team” This is the most ambitious category: Jimini/Sage and, to a degree, Wysa Copilot. The AI interacts with the patient between appointments while keeping the human clinician in the loop. Jimini explicitly describes Sage as an “AI Care Team Member,” rather than a replacement clinician.M13+1

2. “AI makes the psychiatrist dramatically more capable” Blossom is particularly interesting here. Its thesis is that psychiatry's constraint is clinician time, so the copilot handles pieces of the work around the psychiatrist rather than simply generating documentation. It raised $20M in seed/Series A financing in March 2026.Fortune+1

3. “Build the intelligence layer around behavioral-health workflows” Companies like Limbic, PsychNow, CogniCare and AARI are attacking specific parts of the clinical loop—intake, assessment, longitudinal tracking, documentation, supervision, etc.PR Newswire+3

If you're looking specifically for the next-generation opportunity

My shortlist would be:

1. Jimini Health — strongest conceptual match for a personalized, longitudinal AI care-team member.
2. Blossom Health — particularly compelling if you're interested in psychiatry + clinician productivity.
3. Wysa — further along in the human + AI hybrid care model.
4. PsychNow — interesting wedge around deep patient understanding before the clinician encounter.
5. Limbic — strong example of AI becoming part of the behavioral-health intake/triage infrastructure.
6. Theris — interesting because it combines the copilot with an actual behavioral-health provider organization.

One adjacent company worth knowing is Legion Health. It's taking a substantially more aggressive route: rather than merely copiloting clinicians, it is building toward autonomous psychiatric care and says it has regulatory authorization for AI-led renewals of certain psychiatric maintenance medications.Y Combinator

If you're doing competitive/market mapping, I can also break these down by funding, founders, launch date, patient/clinician numbers, exact AI workflow, EHR integration, business model, and whether the AI is patient-facing vs clinician-facing—which makes the competitive landscape much clearer.